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 Mast cells play an important role in the immune system by releasing chemicals 
such as chemokines and cytokines once they are stimulated.  These products are released 
after stimulation by a process called mast cell degranulation.  Mast cell degranulation is 
accomplished when vesicles containing the chemicals inside the mast cell fuse with the 
mast cell membrane via SNARE-mediated (Soluble NSF Attachment Protein Receptors) 
membrane fusion.  This family of proteins consists of syntaxin, SNAP 25-like protein, 
and synaptobrevin/VAMP (Vesicle Associated Membrane Protein)(2). Comlexin 
isoforms (complexin 1,2,3,and 4) have been known to regulate this system in a fashion 
that is still unclear.  In order to study the mechanism in which these complexins regulate 
SNARE-mediated membrane fusion, each isoform was cloned and ligated to the pTYB12 
vector to be expressed in E. coli.  An induction process using IPTG was used in order to 
induce production of each isoform via the T7 promoter.  In this experiment, we were able 
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Chapter 1: Introduction 
Membrane fusion is critical in the secretion of biologically active factors such as 
hormones and neurotransmitters, as well as protein transport within the cell.  It requires 
selected proteins and lipids to catalyze a series of steps that lead to the merger of two 
biological membranes (figure 1).  Membrane fusion is catalyzed by a family of proteins 
known as SNARE proteins, which are conserved in all Eukaryotic systems.  The proteins 
that make up this family are syntaxin, SNAP 25-like protein, and synaptobrevin/VAMP 
(vesicle associated membrane protein)(2). These SNAREs fall under two different 
groups: v-SNAREs (VAMPs), which are found on the transport vesicle and t-SNAREs 
(Syntaxins and SNAP 25-like), which are found on the target membrane (1,4). The core 








Figure 1: Membrane fusion via membrane lipids.  As two vesicles 
approach each other (A), the outer regions (red) of both bi-layered 
membranes merge resulting in hemi- fusion (B). The inner layer of the 
bilayer then forms a stalk with only the inner membrane left to 
fuse(C).   The two inner layers of the membrane (orange) then come in 
contact with each other (D).  As fusion continues, the membranes from 
the two vesicles become one continuous membrane allowing for the 
exchange of content between vesicles.  Image from (1) 
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A SNARE complex is formed when SNARE proteins from two opposing 
membranes interact with each other as shown in Figure 2, which then allows for the 
fusion of the two membranes.  Although the general principles for fusion seem to be 
conserved from organism to organism, the regulation of specific SNARE-mediated fusion 





Figure 2:  Proposed model of membrane fusion via SNAREs.  A- 
represents proteins involved. B- step one involves the migration 
of Syntaxin 1A closer to SNAP 25.  SNAP 25 then interacts with 
the H3 (black) domain of Syntain 1A.  As the vesicle approaches 
the target membrane, VAMP 2 interacts with the SNAP 25-H3 
domain complex.  The interaction of these 3 proteins results in 
the formation of a transSNARE complex.  This is followed by 
hemi-fusion then full fusion of the two membranes. 
Image from (1) 
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Although all cells require membrane fusion, certain cells are more specialized in 
SNARE-mediated fusion events, i.e. mast cells.  Mast cells are specialized secretory cells 
that respond to inflammatory signals with the release of a wide variety of products, stored 
in secretory granules, such as histamines, proteases, and cytokines/chemokines (3,4), 
which play important roles in the innate and adaptive immune system.  The release of 
these products is referred to as mast cell degranulation.  Once a mast cell is activated the 
degranulation process begins within a few seconds and is complete 5-10 seconds later (3).  
Degranulation results from a type 1 hypersensitivity reaction. This type of reaction occurs 
when an allergen-antibody complex (allergen that is bound to an IgE immunoglobulin) 
binds to the IgE Fc receptor on the surface of the mast cell.  The binding of the Fc region 
of the allergen-antibody complex to the Fc receptors on the mast cell initiates various 
chemical reactions that lead to degranulation.  Although mast cells are involved in these 
type 1 hypersensitivity reactions they can also promote or suppress inflammation.  Mast 
cells and the chemokines/cytokines and other mediators they secrete activate antigen 
presenting cells, Langerhans cells, and dendritic cells for migration, which can cause 
tissue damage if the response is too strong (5).  It is important to understand various ways 
in which mast cells degranulation can be regulated and how this degranulation can affect 
the immune system.  Recent studies of mast cells have shown that the degranulation 
process relies on the same mechanism of SNARE-mediated membrane fusion in order to 
release the granule contents of the mast cells (4).    
Many different proteins can regulate mast cell-granule fusion via interaction with 
SNARE complexes.  Perhaps the most controversial SNARE regulators are the members 
of the complexin family (4).  There are 4 isoforms in the complexin family: complexin 1, 
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complexin 2, complexin 3, and complexin 4 (1). Complexins were thought to be 
primarily restricted to the nervous system; however, they have been recently identified in 
testis, pancreatic beta cells, and other cells that perform regulated secretion such as mast 
cells.  Complexin 2 has been found to be required for mast cell degranulation (4,8), but 
less is known about the roles of other isoforms in the process. 
A model for the role of complexin in membrane fusion is demonstrated by the 
intricate interaction between complexin 1 and the neuronal SNAREs (Figure 4).  When 
complexin 1 interacts with the SNARE complex, it does not directly bind to an individual 
SNARE protein.  Instead, it interacts with a central α- helical domain within the 
assembled SNARE complex as shown in figure 3 (7).  However, it is unclear whether 
other complexin isoforms regulate membrane fusion in a similar fashion.  By cloning and 






Figure 3 Complexin-SNARE complex in mammals. Blue- 
SNAP 25, Yellow- Syntaxin 1, Red- Synaptobrevin-2( 
VAMP2), Orange- complexin 1.  Complexin 1 binds to the 
SNARE complex in the groove between syntaxin 1 and 
VAMP 2 in an antiparallel fashion with the C terminus of 
complexin lined up with the N terminus of the SNARE 








Figure 4: Possible model for complexin as a regulator. As the SNARE complex 
forms between the two membranes, complexin interacts with the SNARE 
complex inhibiting immediate fusion.  Complexin is released from the SNARE 
complex upon calcium influx and interaction with synaptotagmin-1. Fusion 
occurs after the release of complexin (7). 
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Chapter 2: Materials and Methods 
PCR 
 1uL (100ng/uL) of the plasmid DNA obtained for the complexin 1, 2, 3, and 4 
isoforms were placed in its own PCR tube along with 40uL of HPLC (High performance 
Liquid Chromatography) water, 1uL of 10 uM Nde 1 primer specific for each isoform, 
1uL of 10uM EcoR1 primer specific for each isoform, 5uL of 10x Pfu buffer, 1uL of 
10mM dNTPs (New England Biolabs #N0447S), and 1uL Pfu polymerase (G 
Biosciences part #108P-A).  The PCR was then run using this setup: 94°C/5min(1 cycle), 
94°C/30s, 55°C/30s, 72°C/45s(5 cycles), 94°C/30s, 60°C/30s, 72°C/45s(25 cycles), 
72°C/10min(1 cycle) then 4°C/∞.  After running the PCR, the PCR product was run on at 
100V for 1 hour on a 1% agarose gel.  10uL of each product was mixed with 2uL of 6x 
loading dye and placed in its corresponding well.  A Tridye100bp DNA ladder (#N3271S 
from New England BioLabs) was also used to help verify the product.  The remaining 
40uL of each product was placed in a -20°C freezer for later use.  After the gel run, the 
gel was placed under UV light and a picture was taken and saved on the computer to 
record the results of the gel run. (Note: Complexin 1 and 2 were run with Rat templates 
and complexin 3 and 4 were run with Mouse templates due to availability and the fact 









Table 1 - Primers used for PCR 





























 I Used a Quigen PCR purification kit (50) Cat. No. 28104 to do PCR purification.  
The protocol in the kit was followed using the PCR product from above.  After the 
purification, Nano drop readings were then taken to determine the concentration of the 
DNA (ng/uL)(Table M1). Before beginning restriction digestion, the pTYB12 vector had 
to be isolated using a QIAprep Spin Miniprep kit (250) Cat. No 27106 according to 
protocol.  Nano-drop readings were also taken to determine the concentration of pTYB12 
vector that had been isolated (Table M2). 
Restriction Digestion/Ligation 
 Restriction digestion was set up by adding 42uL of clean PCR product of 
complexin 1,2,3, and 4 to each of 4 tubes and adding 42uL of vector pTYB12 to three 
tubes.  5uL of 10x Ecor1 buffer, 1.5uL of Nde1 (20,000 units/mL) restriction enzyme, 
and 1.5uL of EcoR1 (20,000 units/mL) restriction enzyme were added to each of the 7 
tubes.  The seven tubes were incubated for 2 hours @ 37°C, after two hours, the pTYB12 
vector was heat inactivated at 65°C for 20 min while the other 4 tubes remained in the 
incubator.  After heat activation, the pTYB12 vector was treated with 1uL of CIP enzyme 
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and placed back in the incubator for 1 more hour.  After the hour was complete, the 
products were mixed with 10uL of loading dye and run on a 1% agarose gel at 100V for 1 
hour.  
Next was gel extraction. The gel was placed under UV light and the digested 
products were cut from the gel and placed in 1.5 mL tubes.  Protocol was then followed 
according to the QIAquick Gel Extraction Kit (50) Cat. No. 28704. After the elution of 
the DNA using 50uL of HPLC water, Nano drop readings were again taken to determine 
the concentration of the Digested DNA. (Table M2) 
Ligation of the complexin isoforms and vector pTYB12 was set up using a 10uL 
reaction mixture in a PCR tube. One uL of T4 DNA ligase (#M0202S New England 
BioLabs) and 1uL of 10x buffer for T4 DNA ligase (#B0202S New England BioLabs) 
was then added to each tube.  The amount of vector and insert that needed to be added 
was determined by using 2 formulas: Insert ng = 4[BP insert/BP vector] x vector ng, and 
ng of insert + ng of vector = 100ng.  HPLC water was added to the tubes in order to make 
the reaction mixture total 10uL. The ligation was set up according to Table M3. Once the 
mixtures were complete, the PCR tubes were placed in the PCR machine and incubated at 
17°C overnight and then placed in the 4°C fridge until they were to be used for 
transformation into Novablue. (NOTE: from table M2, pTYB 12 was used for complexin 
2 and 3 and pTYB 12 #1 was used for complexin 1 and pTYB 12 #2 was used for 
complexin 4) 
Transformation into Novablue 
After ligation of the complexin isoforms with the pTYB12 vector, the ligation 
product was transformed into competent Escherichia coli Novablue cells (Novagen).  The 
 
 9 
Novablue cells were removed from the -70°C freezer and thawed on ice for about 5 
minutes.  The cells were then placed in cold 1.5ml micro-centrifuge tubes in 15uL 
aliquots.  1.5uL of each ligation product was placed in its respective tube and mixed with 
cells by gently flicking.  The mixture was then left to incubate in ice for 30 minutes, then 
heat shocked at 42°C in a heating block for 30 seconds, then put back in the ice for 10 
more minutes.  75uL of S0C media was then added to each tube and then incubated at 
37°C for 1 hour.  After the 1-hour incubation, mixture was placed on LB/Ampicillin 
(100ug/mL). The cells were spread out on the plates by shaking the plates back and forth 
with glass beads on them.  The glass beads were removed and the plates were placed in 
the incubator to incubate overnight at 37°C (incubated upside down for the first 20 
minutes). 
Plasmid Isolation/Sequencing 
The following day, colonies were picked for sub-culturing in order to do plasmid 
isolation.  Colonies from each transformation were placed in test tubes with 5mL of 
LB/ampicillin (100ug/ml) broth and grown overnight in a 37°C incubator.  After the 
overnight growth, plasmid isolation of the transformed cells was done using a QIAprep 
Spin Miniprep kit (250) Cat. No 27106 according to protocol.  After the isolation, Nano-
drop reading were taken in order to determine the concentration of the plasmid and the 
plasmids were labeled and stored in the -20°C freezer.   
Using the primer HXO_C63 designed specifically for our plasmids, we prepared 
and sent our plasmids off for sequencing.  The sequencing mixture consisted of 7uL(or 
500-1000ng) of DNA, 2uL of primer, and 3uL of HPLC water (to make total mixture 
12uL).  Once we got the results back, we ran a nucleotide BLAST on the NCBI website 
 
 10 
of our sequence results with the predicted sequence of our complexin isoforms to 
determine if we had any errors in our sequences.  After confirming the sequences of 
complexin 1, 2, 3, and 4, we then proceeded to transform the plasmids into E. coli 
Rosetta 2(DE3) competent cells. (Novagen) 
Transformation into Rosetta 2 (DE3) 
Rosetta 2 (DE3) cells were taken out of the -70°C freezer and thawed on ice for 
about 5 minutes.  These cells were then placed into a 1.5mL micro-centrifuge tube in 
10uL aliquots. 1ul of each plasmid was then added to its respective tube that had 10uL of 
Rosetta 2 cells and incubated on ice for 30 min.  The cells were then heat shocked in a 
heating block at 42°C for 30 seconds and placed back in the ice to incubate for 10 more 
minutes.  90uL of LB broth was added to each tube and incubated at 37°C for 1 hour.  
50uL of the cells were then put on an LB/ampicillin (100ug/mL)/chloramphenicol 
(34ug/mL) plate and rolled with glass beads to spread out the bacteria.  The plates were 
then incubated overnight at 37°C.   
Small-Scale Induction 
Small-scale induction of the complexin 1, 2, 3, and 4 isoforms was done by 
making overnight cultures from the transformation of the vector and isoform into Rosetta 
2 (DE3).   First, OD600 readings were taken from the overnight cultures.  Using these 
readings and the formula C1V1=C2V2 each culture was normalized to .1 in 10mL of LB 
both with 10uL of Ampicillin 100 and 10uL of Chloramphenicol 34.  Each culture was 
then split into 2 duplicates of 5mL each. One duplicate was labeled with a “+” and the 
other duplicate with a “ - ” to indicate which will be induced with IPTG.  These 
duplicates were placed in the incubator at 37°C/220rpm for 2 hours. After 2 hours, the 
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OD600 was taken again and if these readings were between .4 and .8 then 2.5uL of IPTG 
was added to the tubes labeled with a +.  After adding IPTG the tubes were placed back 
into the incubator at 37°C/220rpm for 4 more hours.  After the 4-hour incubation, the 
OD600 was taken again. Samples were then taken for analysis on SDS-PAGE  
SDS-PAGE 
SDS-PAGE gels were created as the following: 
Table 2 - 10% SDS-PAGE gels 
10% SDS-PAGE Gels (Bottom Layer)  
Millipore Water 7.9mL 
1.5M Tris [pH 8.8] 5.0mL 
30% acrylamide 6.7mL 
10% SDS 200µL 
10% Ammonium Persulfate 200µL 
TEMED 8µL 
  
Table 3 - 5% stacking layer 
5% Stacking Layer  
Millipore Water 5.5mL 
1.0M Tris [pH 6.8] 1.0mL 
30% acrylamide 1.3mL 
10% SDS 80µL 
10% Ammonium Persulfate 80µL 
TEMED 8µL 
 
Bottom Layer mixed together, after addition of TEMED, 4.5mL of solution was 
poured into 1mm glass plates and covered with a layer of isopropanol until 
solidified. Isopropanol was removed by rinsed with distilled water, and 5% stacking 
layer was poured on top with appropriate combs for wells inserted. Used once 
solidified. 
Samples were prepared for SDS-PAGE through the following: 1OD of cell culture 
spun down in 1.5mL microcentrifuge tube, then resuspended in 2x SDS sample 
Buffer by vortexing. For lysis, 0.5mm glass beads were added and vortexed for 1min 
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after addition of 1mM PMSF. Samples were boiled @ 95°C for 5min. Samples cooled 
to room temperature before loading. 
Samples loaded in gel in appropriate manner. 10µL of Broad Range Standard 
(BioRad), and 15µL of samples. 
Run at 150V/1hr in BioRad Mini-PROTEAN Tetra System. 
For staining, the gels were soaked in Fixing Solution for 30min (45% methanol, 10% 
acetic acid), the Coomassie Blue Staining Solution (45%methanol, 10%acetic acid, 
0.05% w/v Coomassie Brilliant Blue R-250) for 1 hr, then destained overnight in 
Destaining Solution (5% methanol, 7% acetic acid) 
 
Chapter 3: Data and Results 
 
 We used the complexin 1 and 2 cDNA obtained from rat and the complexin 3 and 
4 cDNA obtained from mouse and amplified it using PCR.  We then took the amplified 
DNA specific for each complexin isoform and did restriction digestion and ligation to the 
pTYB12 vector so the plasmid could be transformed into E.coli for expression.  After 
expression the plasmids were re-isolated for sequencing and transformation into Rosetta 













Table M1 - Nano-drop readings after PCR cleanup 
 ng/uL 260/280 260/230 
Complexin I 37.1 1.94 1.96 
Complexin II 17.8 1.93 2.09 
Complexin III 36.6 1.89 2.12 
Complexin IV 43.3 1.87 2.09 
 
 
Table M2 - Nano-drop reading after gel extraction/pTYB12 vector isolation 
 ng/uL 260/280 260/230 
Complexin I 12.6 2.14 0.07 
Complexin II 8.9 2.09 0.03 
Complexin III 18.9 2.05 0.05 
Complexin IV 19.3 1.84 0.15 
pTYB 12 21.5 1.90 0.03 
pTYB 12 #1 15.3 2.18 0.07 
pTYB 12 #2 13.7 1.94 0.10 
 
Figure 5: Left: Visible band of the 
complexin 1 PCR product in well 1 
and complexin 4 product in well 2.  
Middle:  Visible band of complexin 2 
PCR product in well 1. Right: Visible 




Table M3 - ligation set up 
 Complexin I Complexin II Complexin III Complexin IV 
T4 Ligase 1uL 1uL 1uL 1uL 
10x buffer 1uL 1uL 1uL 1uL 
pTYB 12 
vector 
5.3uL 3.7uL 3.7uL 5.9uL 
Insert 1.4uL 2.2uL 1.1uL 1.1uL 








Figure 6: Complexin 1 sequencing Results matched with Rat complexin 1 






The analysis of the sequencing results by running a protein BLAST of the amino acid 
sequence of the complexin 1 template and the subject showed that the mutation 
from a C to a T was not significant and the amino acid sequence remained 
conserved, confirming our product. 
 
 
Figure 8: Complexin 2 sequencing Results matched with Rat complexin 2 using a 
Nucleotide BLAST on the NCBI website  
 







The analysis of the sequencing results by running a protein BLAST of the amino acid 
sequence of the complexin 2 template and the subject showed that the one mutation 
from an A to a G was not significant and the amino acid sequence remained 
conserved, confirming our product. Also, the N at base 512 in the sequencing results 
for complexin 2 was determined to be a G meaning that there was no mutation 
there.  This N corresponds with amino acid 133, which is why the protein BLAST of 
complexin 2 has an X at amino acid 133.  Since there was no nucleotide mutation 
there was also no amino acid mutation. 
 
 





Analysis of the sequencing results confirmed that the complexin 3 was successfully 
transformed into E.coli without any errors in the DNA.   
SDS-PAGE results 
    
 
Figure 10: Complexin 3 sequencing Results matched with mouse complexin 3 by 









Figure 12: PCR confirmation of 
complexin 4 plasmid after no 
results were returned from 
sequencing.   
Figure 11: SDS-PAGE results for each complexin isoform.  Complexin 1 had a 
visible band at 75kDa confirming expression.  Complexin 2 had a visible band at 
59kd. This was the wrong size for the vector and insert.  Complexin 3 had a visible 
band at 75kd confirming expression.  There was no visible band for complexin 4. 
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Chapter 4: Discussion 
 In order to be able to use an in vitro fusion assay to study the roles of the four 
complexin isoforms in regulation of SNARE-mediated fusion, each isoform had to be 
purified.  This was done through cloning into an expression vector, then transformation 
into E. coli Rosetta 2 (DE3) expression strain.  Using the T7 expression system, and 
IPTG induction allowed us to verify expression of these isoforms in E. coli. Each of these 
isoforms was tagged with a chitin-binding domain that is present in the pTYB12 vector, 
which will allow for specific purification of each isoform by using the NEB IMPACT 
system.  
 We were successful in amplifying the DNA for all the complexin isoforms by 
doing a PCR as seen in figure 5.  After PCR, we digested the PCR product and the 
pTYB12 vector with restriction enzymes NdeI and EcoRI to prepare for ligation.  After 
ligation, the recombinant plasmid with the vector and complexin isoform was 
transformed into E. coli for expression. We then re-isolated the plasmid from the E. coli 
to send it off for sequencing to ensure we had the correct insert without any errors.   
 We were able to confirm the sequences for complexin 1, 2, and 3. In order to 
confirm the sequences for complexin 1 and 2, we had to run a protein BLAST of the 
template protein sequence with the translated sequence of both complexin 1 and 2 to 
ensure that there was not an error in the amino acid sequence even though there were 
errors in the DNA sequence as seen in figures 6-10.  After multiple attempts we have still 
not received a complete, confirmed sequence from the sequencing company of complexin 
4.  The first time we sequenced it, we did not get any results back.  So we ran a PCR of 
the recombinant plasmid to be sure that the insert was there.  The PCR confirmed that the 
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insert was indeed there (figure 12), and there must have been an issue with our 
sequencing mixture so we isolated the plasmid again and sent it off for sequencing.  Of 
the results we have obtained, the sequences are still 60-120 base pairs short for 
complexin 4.  
 After confirmation of the other isoforms, we ran a small-scale induction and used 
IPTG to induce T7 promoter and the production of the complexin isoforms.  After 
induction, the samples were run on an SDS-PAGE gel to confirm expression of each 
isoform.  Even though, we did not get the entire sequence for complexin 4, we went 
ahead and did a small-scale induction and SDS-PAGE gel run due to the small chance 
that there was an error in the sequence because the gene is so small and the fact that the 
PCR confirmed that the insert for the protein was present. Of the four isoforms that were 
run, only Complexin 1 and 3 were confirmed at 75kD. Complexin 2 was the wrong size 
at 59kD and there was no visible band for the Complexin 4 sample.  The band at 59kD 
for complexin 2 is the size of the vector without the insert.  Even though we confirmed 
the sequence for complexin 2 after plasmid isolation, the band on the SDS-PAGE gel was 
not the right size. 
 In conclusion, after cloning and expression of all of the Complexin isoforms, we 
were only able to successfully confirm and induce Complexin 1 and 3.  We are currently 
working on going back and cloning Complexin 2 and 4 for expression and induction.  
Once we successfully clone and induce the production of all of the isoforms, each one 
will be isolated using the NEB IMPACT protein purification system to obtain the 
Complexin 1, 2, 3, and 4 isoforms in order to study their regulatory function in SNARE-
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